Novel tPA-neutralising antidote
The availability of an antidote to address possible severe hemorrhage caused by tPA, has the potential to save lives and reduce disability in multiple patients worldwide.
The Problem
tPA is a life-saving drug, but can cause severe bleeding, often into the brain, which is difficult to control. As a result it has limited usage.
The Solution
EmstoPA is an emergency treatment, stopping the bleeding and saving lives as well as reducing disability
Unmet Need
There is a recognised need to be able to rapidly reverse the effects of tPA and EmstoPA is the first such product.